An Antibody-Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with Chemoradiotherapy.
Mol Cancer Ther
; 23(2): 187-198, 2024 Feb 01.
Article
in En
| MEDLINE
| ID: mdl-37828725
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunoconjugates
/
Head and Neck Neoplasms
Limits:
Animals
/
Humans
Language:
En
Journal:
Mol Cancer Ther
Journal subject:
ANTINEOPLASICOS
Year:
2024
Document type:
Article
Affiliation country:
Country of publication: